Case Report: Re-Treatment With Lu-DOTATATE in Neuroendocrine Tumors

Peptide receptor radionuclide therapy (PRRT) is an established treatment in advanced neuroendocrine tumors (NETs), which overexpressed somatostatin receptors. However, after progression there are a limited number of available treatments. We want to share a case report about a patient with a NET re-t...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Front Endocrinol (Lausanne)
Prif Awduron: Vida Navas, Elena María, Martínez Lorca, Alberto, Sancho Gutiérrez, Aintzane, Sanz Gómez, Lucia, Navarro Martínez, Teresa, Grande Pulido, Enrique, Carrato Mena, Alfredo, Gajate Borau, Pablo
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Frontiers Media S.A. 2021
Pynciau:
Endocrinology
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8082310/
https://ncbi.nlm.nih.gov/pubmed/33935979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2021.676973
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg